The Efficacy and Safety of Thalidomide in Preventing CINV Induced by Cisplatin-containing Chemotherapy

NCT03601871 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

880

Enrollment

OTHER

Sponsor class

Conditions

Chemotherapy-induced Nausea and Vomiting

Interventions

DRUG: Thalidomide
DRUG: Dexamethasone
DRUG: 5-HT3 antagonists

Sponsor

Yunpeng Liu